Literature DB >> 29401362

Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.

Shawn T Clark1, David S Guttman2,3, David M Hwang1,4.   

Abstract

The evolution and diversification of bacterial pathogens within human hosts represent potential barriers to the diagnosis and treatment of life-threatening infections. Tremendous genetic and phenotypic diversity is characteristic of host adaptation in strains of Pseudomonas aeruginosa that infect the airways of individuals with chronic lung diseases and prove to be extremely difficult to eradicate. In this MiniReview, we examine recent advances in understanding within-host diversity and antimicrobial resistance in P. aeruginosa populations from the lower airways of individuals with the fatal genetic disease cystic fibrosis and the potential impacts that this diversity may have on detecting and interpreting antimicrobial susceptibility within these populations.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29401362     DOI： 10.1093/femsle/fny026

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  8 in total

1.  The Nutritional Environment Is Sufficient To Select Coexisting Biofilm and Quorum Sensing Mutants of Pseudomonas aeruginosa.

Authors:  Michelle R Scribner; Amelia C Stephens; Justin L Huong; Anthony R Richardson; Vaughn S Cooper
Journal:  J Bacteriol       Date:  2022-01-03       Impact factor: 3.476

Review 2.  Harnessing bacterial interactions to manage infections: a review on the opportunistic pathogen Pseudomonas aeruginosa as a case example.

Authors:  Chiara Rezzoagli; Elisa T Granato; Rolf Kümmerli
Journal:  J Med Microbiol       Date:  2020-01-21       Impact factor: 2.472

Review 3.  Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.

Authors:  Rutvij A Khanolkar; Shawn T Clark; Pauline W Wang; David M Hwang; Yvonne C W Yau; Valerie J Waters; David S Guttman
Journal:  mSystems       Date:  2020-12-01       Impact factor: 6.496

Review 4.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

5.  Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.

Authors:  Jad Atrissi; Annalisa Milan; Raffaela Bressan; Marianna Lucafò; Vincenzo Petix; Marina Busetti; Lucilla Dolzani; Cristina Lagatolla
Journal:  Microbiol Spectr       Date:  2021-09-29

6.  Architecture of cell-cell junctions in situ reveals a mechanism for bacterial biofilm inhibition.

Authors:  Charlotte E Melia; Jani R Bolla; Stefan Katharios-Lanwermeyer; Daniel B Mihaylov; Patrick C Hoffmann; Jiandong Huo; Michael R Wozny; Louis M Elfari; Jan Böhning; Ashleigh N Morgan; Charlie J Hitchman; Raymond J Owens; Carol V Robinson; George A O'Toole; Tanmay A M Bharat
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 12.779

7.  Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission.

Authors:  Conrad Izydorczyk; Barbara Waddell; Brett D Edwards; Jasper Greysson-Wong; Michael G Surette; Ranjani Somayaji; Harvey R Rabin; John M Conly; Deirdre L Church; Michael D Parkins
Journal:  Front Microbiol       Date:  2020-03-20       Impact factor: 5.640

8.  Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.

Authors:  Trenton J Davis; Ava V Karanjia; Charity N Bhebhe; Sarah B West; Matthew Richardson; Heather D Bean
Journal:  mSphere       Date:  2020-10-07       Impact factor: 4.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.